M&A, lumbar fusions & more — Top trends driving global spinal biologics market

Written by Megan Wood | January 22, 2018 | Print  |

Technavio analysts identified the top three trends of the global spinal biologics market between 2018 and 2022.

Here are the three trends boosting the global spinal biologics market.

 

1. Escalating strategic alliances. The spinal biologics field will see a lot of merger and acquisition activity, with the goal of increasing products and expanding globally. The report highlights ChoiceSpine acquiring Exactech's spinal assets.

 

2. Increasing number of lumbar fusion cases. An increasing geriatric population coupled with a growing number of accidents will boost the number of lumbar spinal fusion cases.

 

3. Rising adoption of minimally invasive surgery. With the growing popularity of MIS, many vendors are introducing innovative technology. Patients are demanding treatments that offer quicker recoveries.

 

More articles on biologics:
GE Healthcare assists CBMG accelerate cell therapy manufacturing: 5 insights
Major breakthroughs in spinal biologics, disc regeneration on the horizon: 3 key thoughts from Dr. William Watters
Mayo Clinic receives FDA approval for stem cell reproduction system: 5 insights

 

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months